SECOND METABOLOME

Welcome to the Brand page for “SECOND METABOLOME”, which is offered here for Therapeutic pharmaceutical for the treatment of inflammatory, autoimmune, and metabolic diseases, and for immuno-oncology therapy;.

Its status is currently believed to be active. Its class is unavailable. “SECOND METABOLOME” is believed to be currently owned by “Second Genome, Inc.”

Owner:
SECOND GENOME, INC.
Owner Details
Description:
Therapeutic pharmaceutical for the treatment of inflammatory, autoimmune, and metabolic diseases, and for immuno-oncology therapy;
Categories: THERAPEUTIC PHARMACEUTICAL TREATMENT